Literature DB >> 26069721

Functions of Müller cell-derived vascular endothelial growth factor in diabetic retinopathy.

Juan-Juan Wang1, Meili Zhu1, Yun-Zheng Le1.   

Abstract

Müller cells are macroglia and play many essential roles as supporting cells in the retina. To respond to pathological changes in diabetic retinopathy (DR), a major complication in the eye of diabetic patients, retinal Müller glia produce a high level of vascular endothelial growth factor (VEGF or VEGF-A). As VEGF is expressed by multiple retinal cell-types and Müller glia comprise only a small portion of cells in the retina, it has been a great challenge to reveal the function of VEGF or other globally expressed proteins produced by Müller cells. With the development of conditional gene targeting tools, it is now possible to dissect the function of Müller cell-derived VEGF in vivo. By using conditional gene targeting approach, we demonstrate that Müller glia are a major source of retinal VEGF in diabetic mice and Müller cell-derived VEGF plays a significant role in the alteration of protein expression and peroxynitration, which leads to retinal inflammation, neovascularization, vascular leakage, and vascular lesion, key pathological changes in DR. Therefore, Müller glia are a potential cellular target for the treatment of DR, a leading cause of blindness.

Entities:  

Keywords:  Blood-retina barriers; Diabetic retinopathy; Inflammation; Müller glia; Protein modification; Vascular endothelial growth factor

Year:  2015        PMID: 26069721      PMCID: PMC4458501          DOI: 10.4239/wjd.v6.i5.726

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  65 in total

Review 1.  Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis.

Authors:  Y Dor; R Porat; E Keshet
Journal:  Am J Physiol Cell Physiol       Date:  2001-06       Impact factor: 4.249

2.  Serous macular detachment in diabetic cystoid macular oedema.

Authors:  Hakan Ozdemir; Murat Karacorlu; Serra Karacorlu
Journal:  Acta Ophthalmol Scand       Date:  2005-02

3.  Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.

Authors:  N Ferrara; W J Henzel
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

4.  Significance of outer blood-retina barrier breakdown in diabetes and ischemia.

Authors:  Hui-Zhuo Xu; Yun-Zheng Le
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-05       Impact factor: 4.799

5.  Unexpected transcriptional activity of the human VMD2 promoter in retinal development.

Authors:  Meili Zhu; Lixin Zheng; Yumi Ueki; John D Ash; Yun-Zheng Le
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

6.  Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.

Authors:  A J Barber; E Lieth; S A Khin; D A Antonetti; A G Buchanan; T W Gardner
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

7.  Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

Authors:  Kazuaki Nishijima; Yin-Shan Ng; Lichun Zhong; John Bradley; William Schubert; Nobuo Jo; Jo Akita; Steven J Samuelsson; Gregory S Robinson; Anthony P Adamis; David T Shima
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

8.  Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate.

Authors:  A P Adamis; D T Shima; M J Tolentino; E S Gragoudas; N Ferrara; J Folkman; P A D'Amore; J W Miller
Journal:  Arch Ophthalmol       Date:  1996-01

9.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

10.  Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors.

Authors:  Magali Saint-Geniez; Arindel S R Maharaj; Tony E Walshe; Budd A Tucker; Eiichi Sekiyama; Tomoki Kurihara; Diane C Darland; Michael J Young; Patricia A D'Amore
Journal:  PLoS One       Date:  2008-11-03       Impact factor: 3.240

View more
  22 in total

1.  p38MAPK plays a critical role in induction of a pro-inflammatory phenotype of retinal Müller cells following Zika virus infection.

Authors:  Shuang Zhu; Huanle Luo; Hua Liu; Yonju Ha; Elizabeth R Mays; Ryan E Lawrence; Evandro Winkelmann; Alan D Barrett; Sylvia B Smith; Min Wang; Tian Wang; Wenbo Zhang
Journal:  Antiviral Res       Date:  2017-07-21       Impact factor: 5.970

2.  Probucol promotes high glucose-induced proliferation and inhibits apoptosis by reducing reactive oxygen species generation in Müller cells.

Authors:  Xuxia Zhou; ShiBei Ai; ZhongPing Chen; ChenXiang Li
Journal:  Int Ophthalmol       Date:  2019-05-29       Impact factor: 2.031

3.  Expression, distribution and function of kinin B1 receptor in the rat diabetic retina.

Authors:  Soumaya Hachana; Menakshi Bhat; Jacques Sénécal; Frédéric Huppé-Gourgues; Réjean Couture; Elvire Vaucher
Journal:  Br J Pharmacol       Date:  2018-02-13       Impact factor: 8.739

4.  Progression of Diabetic Capillary Occlusion: A Model.

Authors:  Xiao Fu; John Scott Gens; James A Glazier; Stephen A Burns; Thomas J Gast
Journal:  PLoS Comput Biol       Date:  2016-06-14       Impact factor: 4.475

Review 5.  VEGF production and signaling in Müller glia are critical to modulating vascular function and neuronal integrity in diabetic retinopathy and hypoxic retinal vascular diseases.

Authors:  Yun-Zheng Le
Journal:  Vision Res       Date:  2017-06-21       Impact factor: 1.886

6.  Regulation of Adrenergic, Serotonin, and Dopamine Receptors to Inhibit Diabetic Retinopathy: Monotherapies versus Combination Therapies.

Authors:  Timothy S Kern; Yunpeng Du; Jie Tang; Chieh Allen Lee; Haitao Liu; Alyssa Dreffs; Henri Leinonen; David A Antonetti; Krzysztof Palczewski
Journal:  Mol Pharmacol       Date:  2021-08-15       Impact factor: 4.054

7.  Th22 cells induce Müller cell activation via the Act1/TRAF6 pathway in diabetic retinopathy.

Authors:  Yufei Wang; Hongdan Yu; Jing Li; Wenqiang Liu; Shengxue Yu; Pan Lv; Lipan Zhao; Xiaobai Wang; Zhongfu Zuo; Xuezheng Liu
Journal:  Cell Tissue Res       Date:  2022-10-06       Impact factor: 4.051

Review 8.  Müller cells and diabetic retinopathy.

Authors:  Brandon A Coughlin; Derrick J Feenstra; Susanne Mohr
Journal:  Vision Res       Date:  2017-09-05       Impact factor: 1.886

9.  High Glucose and Glucose Deprivation Modulate Müller Cell Viability and VEGF Secretion.

Authors:  S Vellanki; A Ferrigno; Y Alanis; B S Betts-Obregon; A T Tsin
Journal:  Int J Ophthalmol Eye Sci       Date:  2016-02-15

10.  VEGF Mediates Retinal Müller Cell Viability and Neuroprotection through BDNF in Diabetes.

Authors:  Yun-Zheng Le; Bei Xu; Ana J Chucair-Elliott; Huiru Zhang; Meili Zhu
Journal:  Biomolecules       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.